Saturday, July 11, 2026

Drug profile · INN

etoposide-cisplatin

etoposide-cisplatin is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — etoposide-cisplatin
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

etoposide-cisplatin is an FDA-listed pharmaceutical active ingredient.

Key facts

INN etoposide-cisplatin

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. D926TC00001 Phase 3 · AstraZeneca · Stage I adenocarcinoma non-small cell lung cancer (NSCLC) wi
  2. D6186C00001 Phase 2 · AstraZeneca · Advanced Non-Small Cell Lung Cancer
  3. UC-IMM-2302 Phase 2 · Ningbo Cancer Hospital · Patients with dMMR/MSI (non-colorectal/non-endometrial) loca

Frequently asked questions

What is etoposide-cisplatin?

etoposide-cisplatin is an FDA-listed pharmaceutical active ingredient.